BMS-960
CAS No. 1265321-86-5
BMS-960( —— )
Catalog No. M34189 CAS No. 1265321-86-5
BMS-960 is an S1P agonist with potential anti-tumour activity for cancer research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 889 | In Stock |
|
| 10MG | 1131 | In Stock |
|
| 25MG | 1606 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBMS-960
-
NoteResearch use only, not for human use.
-
Brief DescriptionBMS-960 is an S1P agonist with potential anti-tumour activity for cancer research.
-
DescriptionBMS-960 is an S1P agonist with potential anti-tumour activity for cancer research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetS1P Receptor
-
RecptorS1P Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1265321-86-5
-
Formula Weight528.48
-
Molecular FormulaC26H23F3N4O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(F)(F)(F)C1=C(ON=C1C2=CC=CC=C2)C3=NC(=NO3)C4=CC=C([C@@H](CN5C[C@@H](C(O)=O)CCC5)O)C=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
4-Deoxypyridoxine hy...
4-Deoxypyridoxine (hydrochloride) inhibits the degradation of intracellular S1P by inhibiting S1P lyase (SPL) activity, minimized the chemically induced apoptosis of insulinoma cell lines as S1P did.
-
MP-A08
MP-A08 is a highly selective ATP competitive inhibitor of sphingosine kinase (SPHK1) that targets both SphK1 and SphK2 (Ki: 6.9 ± 0.8 μM and 27 ± 3 μM, respectively).
-
SKI V
SKI V is a potent and noncompetitive non-lipid sphingosine kinase (SPHK; SK) inhibitor (GST-hSK,IC50 : 2 μM), and is a PI3K inhibitor(hPI3k,IC50 : 6 μM), induces apoptosis and has antitumor activity
Cart
sales@molnova.com